Catalog #CP156

RecombiMAb mouse IgG2a (LALA-PG) isotype control, unknown specificity

Clone MOPC-21-CP156
Isotype Mouse IgG2a
(switched from mouse IgG1)

$243.00 - $6,614.50

$243.00 - $6.00

Choose an Option...
  • 100 mg - $6,614.50
  • 50 mg - $4,734.00
  • 25 mg - $3,293.50
  • 5 mg - $943.00
  • 1 mg - $243.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left
US Customers - Order within 21 hours, 12 minutes to receive by November 19.

Product Description

The MOPC-21-CP156 monoclonal antibody is a recombinant version of the original MOPC-21 antibody. The variable domain sequences are identical to the original MOPC-21 antibody but the constant region sequences have been switched from mouse IgG1 to mouse IgG2a. The LALA-PG substitution has been shown to decrease effector functions by disrupting the Fc/Fcγ receptor interface. The MOPC-21-CP156 monoclonal antibody is ideal for use as a non-reactive isotype-matched control for mouse IgG2a antibodies with a LALA-PG mutation in in vivo and in vitro applications.

Specifications

Isotype Mouse IgG2a, κ
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Conjugation This product is unconjugated. Conjugation is available via our Antibody Conjugation Services.
Mutations LALA-PG
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin ≤0.5EU/mg (≤0.0005EU/μg)
Determined by LAL assay
Aggregation <5%
Determined by SEC
Purity ≥95%
Determined by SDS-PAGE
Sterility 0.2 µm filtration
Production Purified from CHO cell supernatant in an animal-free facility
Purification Protein G
RRID AB_3696239
Molecular Weight 150 kDa
Murine Pathogen Tests Ectromelia/Mousepox Virus: Negative
Hantavirus: Negative
K Virus: Negative
Lactate Dehydrogenase-Elevating Virus: Negative
Lymphocytic Choriomeningitis virus: Negative
Mouse Adenovirus: Negative
Mouse Cytomegalovirus: Negative
Mouse Hepatitis Virus: Negative
Mouse Minute Virus: Negative
Mouse Norovirus: Negative
Mouse Parvovirus: Negative
Mouse Rotavirus: Negative
Mycoplasma Pulmonis: Negative
Pneumonia Virus of Mice: Negative
Polyoma Virus: Negative
Reovirus Screen: Negative
Sendai Virus: Negative
Theiler’s Murine Encephalomyelitis: Negative
Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
Need a Custom Formulation? See All Antibody Customization Options

Product Citations

  • Gammaherpesvirus infection impairs lung fibrosis resolution through PD-L1+ fibroblasts and PD-1+ CD8+ T cell interaction.

    In Mucosal Immunol on 1 October 2026 by Kempen, L., Vanneste, D., et al.

    PubMed

    Pulmonary fibrosis is a complex disease with poorly understood, multifactorial triggers. Gammaherpesviruses (γHVs), including Epstein-Barr virus in humans and Murid herpesvirus 4 (MuHV-4) in mice, have been linked to pulmonary fibrosis exacerbation, although the underlying mechanisms remain unclear. This study explores how γHV infection modulates bleomycin (bleo)-induced lung fibrosis in mice, using flow cytometry and multiplex spectral immunofluorescence (MSI) to analyze cell dynamics, localization, and intercellular crosstalk. Despite the substantial contribution of monocytes (MOs) to the alveolar macrophage (AM) pool following MuHV-4 infection, these cells do not exhibit overt profibrotic properties upon bleo treatment. In contrast, MuHV-4 infection led to the accumulation of activated, IFNγ-producing memory CD8+ T cells in the lungs of bleo-treated mice, with MSI revealing their enrichment and colocalization with fibroblasts. Notably, fibroblasts showed increased IFNγ-induced PD-L1 expression, while T cells upregulated PD-1, co-localizing in fibrosis-rich regions. In vivo neutralization of the PD-L1/PD-1 axis after bleo treatment significantly improved the resolution of fibrosis in MuHV-4-infected mice, highlighting the key pathogenic role of this interaction in sequelae persistence. Compared to fibroblasts cocultured with T cells from naïve mice, those cocultured with MuHV-4-induced T cells exhibited significantly increased collagen expression, while this effect was abrogated by PD-1 blockade. Similar results were observed in cocultures of human fibroblasts and CD8+ T cells isolated from EBV-infected patients, underscoring the translational potential of these findings. Collectively, our findings identify interactions between PD-1+ CD8+ T cells and PD-L1+ fibroblasts as central drivers of persistent lung fibrosis associated with γHV infection.

Product FAQs

Related Products

  1. Catalog #BE0369
    InVivoMAb polyclonal llama IgG Read more
  2. Catalog #BP0290
    InVivoPlus rat IgG1 isotype control, anti-trinitrophenol Read more
  3. Catalog #BP0087
    InVivoPlus polyclonal Syrian hamster IgG Read more
  4. Catalog #BE0087
    InVivoMAb polyclonal Syrian hamster IgG Read more
  5. Catalog #BE0094
    InVivoMAb polyclonal rat IgG Read more
  6. Catalog #BE0095
    InVivoMAb polyclonal rabbit IgG Read more
  7. Catalog #BE0093
    InVivoMAb polyclonal mouse IgG Read more
  8. Catalog #BE0092
    InVivoMAb polyclonal human IgG Read more
  9. Catalog #BE0130
    InVivoMAb polyclonal goat IgG Read more
  10. Catalog #BE0290
    InVivoMAb rat IgG1 Isotype control, anti-trinitrophenol Read more

Additional Formats

  1. Catalog #CP160
    RecombiMAb mouse IgG2a isotype control, unknown specificity Read more